ABNCoV2

ABNCoV2 vaccine · Bavarian Nordic

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABNCoV2, covering 2024-02-12 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 [Phase 3]